Howard Horn

Howard Horn

Chief Financial Officer, Corporate Strategy and Executive Vice PresidentatUltragenyx Pharmaceutical· In proxies 2023–2025

Pay in FY2025-13% from the year before · Ultragenyx Pharmaceutical stock -45.3% the same year

Howard Horn was paid $3.8M in FY2025 (Dec), down 13%. Ultragenyx Pharmaceutical stock fell 45.3% that year.

Pay$100 in the stock at the end of FY22 → $50
Pay is from the Summary Compensation Table of each Ultragenyx Pharmaceutical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Ultragenyx PharmaceuticalPublic company · 3 yr
    • Chief Financial Officer, Corporate Strategy and Executive Vice President2023 – Present · 3 yrStock in role -60%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?